Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 3, 2014, Pages 371-374

  Shan, Zhou ^a   Yang, Guo ^a   Xiang, Wang ^a   Pei Jun, Wang ^a   Bin, Zhang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Invasion; Migration; OSCC; Resveratrol

Indexed keywords

RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL STRAIN KB; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVALUATION STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; MTT ASSAY; PRIORITY JOURNAL; TRANSWELL ASSAY;

ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLORIMETRY; HUMANS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; STILBENES;

EID: 84896727930     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1575-1     Document Type: Article

References (27)

1. Athar M, Back JH, Kopelovich L et al (2009) Multiple molecular target of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys 486:95-102
2. Colin D, Gimazane A, Lizard G, Izard JC, Solary E, Latruffe N et al (2009) Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5 fluoro-uracil sensitivity in human derived colon cancer cells. Int J Cancer 124:2780-2788
3. Felding-Habermann B (2003) Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20:203-213
4. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277-279
5. Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA (2007) Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28:1946-1953
6. Kowalski LP, Bagietto R, Lara JR et al (2003) Prognoslic signilicance of the distribution of neck metastasis from oral carcinoma. Herd Neck 22:207-214
7. Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84:359-369
8. Li XM, Di B, YD S et al (2005) Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma. Chin J Cancer 24:208-212
9. Li Y, Xu Y, Huang D, Jiang L, Li K (2007) Inhibit effection of resveratrol on the growth of Hep-2 cell line. J Clin Otorhinolaryngol Head Neck Surg 21:1129-1131
10. Lin HY, Lansing L, Merillon JM, Davis FB, Tang HY, Shih A et al (2006) Integrin alphaVbeta3 contains a receptor site for resveratrol. Faseb J 20:1742-1744
11. Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D et al (2008) Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29:62-69
12. Marier JF, Chen K, Prince P et al (2005) Production of exvivo lipopolysaccl1aride induced tumor necrosis factor - alpha, interleukjn-1 beta, and interleukin - is suppressed by trans-resveratrol in a concentration dependent manner. Can J Vet Res 69:151-154
13. Narayanan BA, Narayanan NK, Re GG et al (2003) Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104:204-212
14. Noguchi M, Kido Y, kubota H et al (1999) Prognostic factors and relative risk for survival in NI-3 oral squamous cell carcinoma: a multivariate analysis using cox's hazard model. Br J Oral Maxillolac Surg 37:433-437
15. Qin YM, Li K, He TP, Mo LE, Liang NC (2007) Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro. Zhong Yao Cai 30:176-178
16. Sun Z, Yao HY (2005) Inhibitory effects of zeaxanthin from corn gluten meal on human oral squamour cell carcinoma. J Food Sci Biotechnol 24:34-37
17. Sun NJ, Woo SH, Cassady JM, Snapka RM (1998) DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61:362-366
18. Sun CY, Hu Y, Guo T, Wang HF, Zhang XP, He WJ et al (2006) Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity. Acta Pharmacol Sin 27:1447-1452
19. Tang FY, Chiang EP, Sun YC (2008a) Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem 19:287-294
20. Tang FY, Su YC, Chen NC, Hsieh HS, Chen KS (2008b) Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol Nutr Food Res 52:683-691
21. Ulrich S, Woltern F, Stein JM (2005) Molecuar mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 49:452-461
22. Waas ET, Wobbes T, Lomme RM, DeGroot J, Ruers T, Hendriks T (2003) Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90:1556-1564
23. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS et al (2004) Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23:1845-1853
24. Wu H, Liang X, Fang Y, Qin X, Zhang Y, Liu J (2008) Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed Pharmacother 62:613-621
25. Xu YP, Zhao XQ, Sommer K, Moubayed P (2003) Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis. J Zhejiang Univ Sci 4:491-501
26. Yang Z, Zhang B, Mi L (2011) The research of anti-proliferation and induction of apoptosis of resveratrol on human oral squamous cell carcinoma KB cells in vitro. LiaoNing J Tradit Chin Med 38:740-743
27. Zhao R, Jia RD, Wang HJ (2011) Effects of paclitaxel on growth inhibition and pro-apoptosis of human carcinoma of mouth floor KB cells. Chin J Exp Tradit Med 17:177-180